The reduced production of IGF-1 in type 1 diabetes likely plays a pathogenic role in diabetic cardiomyopathy and strongly suggests that the cardioprotective effects of B12 is due partly to the restoration of IGF-1 levels. This evidence concerns the gene IGF1 and type 1 diabetes mellitus.